Acumen Pharmaceuticals, Inc. (NAS: ABOS) Stock Analysis & Fundamentals | ScreenerHero

Create free account

ABOSAcumen Pharmaceuticals, Inc.

NAS · US · Healthcare · Biotechnology · acumenpharm.com

2.170USD-2.25%Mkt Cap: 156.73M $P/E: —1d ago

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. It focuses on advancing a targeted immunotherapy drug candidate, sabirnetug …

Industry Peers

Biotechnology

Vertex Pharmaceuticals Incorporated

$123.36BUSDP/E 28.9

Regeneron Pharmaceuticals, Inc.

$71.18BUSDP/E 16.6

$51.14BUSDP/E 38.1

$49.51BUSDP/E 29.8

Revolution Medicines, Inc.

Alnylam Pharmaceuticals, Inc.

$37.80BUSDP/E 71.0

Royalty Pharma plc

$33.70BUSDP/E 30.8

Incyte Corporation

$23.30BUSDP/E 16.5

Insmed Incorporated

$16.71BUSDP/E 21.6

BridgeBio Pharma, Inc.

$14.00BUSDP/E 18.4

Madrigal Pharmaceuticals, Inc.

Axsome Therapeutics, Inc.

ABIVAX Société Anonyme

BioMarin Pharmaceutical Inc.

$11.60BUSDP/E 43.2

Bio-Techne Corporation

$11.18BUSDP/E 102.5

Cytokinetics, Incorporated

Summit Therapeutics Inc.

Financière de Tubize SA

$9.97BUSDP/E 98.1

Apogee Therapeutics, Inc.

Krystal Biotech, Inc.

$10.08BUSDP/E 45.8

Arrowhead Pharmaceuticals, Inc.

Corcept Therapeutics Incorporated

$9.63BUSDP/E 256.3

Kymera Therapeutics, Inc.

Halozyme Therapeutics, Inc.

$9.20BUSDP/E 27.2

Ionis Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc.

Praxis Precision Medicines, Inc.

Protagonist Therapeutics, Inc.

TG Therapeutics, Inc.

$8.41BUSDP/E 19.2

Spyre Therapeutics, Inc.

Immunovant, Inc.

ImmunityBio, Inc.

Rhythm Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc.

Bachem Holding AG

$6.09BUSDP/E 35.9

PTC Therapeutics, Inc.

Cogent Biosciences, Inc.

Scholar Rock Holding Corporation

CG Oncology, Inc.

Belite Bio, Inc

Ligand Pharmaceuticals Incorporated

$5.94BUSDP/E 38.7

Definium Therapeutics, Inc.

Dianthus Therapeutics, Inc.

Travere Therapeutics, Inc.

Oruka Therapeutics, Inc.

Caris Life Sciences, Inc.

Tango Therapeutics, Inc.

Veradermics, Incorporated

Legend Biotech Corporation

ACADIA Pharmaceuticals Inc.

$4.39BUSDP/E 11.6

Viking Therapeutics, Inc.

Relay Therapeutics, Inc.

Edgewise Therapeutics, Inc.

Camurus AB (publ)

$3.58BUSDP/E 55.6

Catalyst Pharmaceuticals, Inc.

$3.85BUSDP/E 18.2

Dyne Therapeutics, Inc.

Enliven Therapeutics, Inc.

Denali Therapeutics Inc.

Parabilis Medicines, Inc.

Arcutis Biotherapeutics, Inc.

Galera Therapeutics, Inc.

$3.47BUSDP/E 0.1

IDEAYA Biosciences, Inc.

BB Biotech AG Ord

Arcus Biosciences, Inc.

Structure Therapeutics Inc.

Zealand Pharma A/S

$2.97BUSDP/E 3.3

Ultragenyx Pharmaceutical Inc.

Beam Therapeutics Inc.

Vera Therapeutics, Inc.

Disc Medicine, Inc.

BioArctic AB (publ)

$2.55BUSDP/E 126.1

Celldex Therapeutics, Inc.

MBX Biosciences, Inc.

Maravai LifeSciences Holdings, Inc.

Kodiak Sciences Inc.

Tarsus Pharmaceuticals, Inc.

Trevi Therapeutics, Inc.

Vericel Corporation

$2.44BUSDP/E 111.2

Nurix Therapeutics, Inc.

Mineralys Therapeutics, Inc.

Kailera Therapeutics, Inc.

SELLAS Life Sciences Group, Inc.

Agios Pharmaceuticals, Inc.

Nektar Therapeutics

Bavarian Nordic A/S

$2.03BUSDP/E 12.2

Palvella Therapeutics, Inc.

Iovance Biotherapeutics, Inc.

Hemab Therapeutics Holdings, Inc.

Sionna Therapeutics, Inc.

ADMA Biologics, Inc.

$2.04BUSDP/E 13.0

Syndax Pharmaceuticals, Inc.

Ocular Therapeutix, Inc.

Viridian Therapeutics, Inc.

Nuvation Bio Inc.

Monte Rosa Therapeutics, Inc.

LAKEFRONT BIOTHERAPEUTICS

$1.85BUSDP/E 3.5

UroGen Pharma Ltd.

Harmony Biosciences Holdings, Inc.

$1.94BUSDP/E 13.5

Nanobiotix S.A.

Rapport Therapeutics, Inc.

Tyra Biosciences, Inc.

Sarepta Therapeutics, Inc.

$1.82BUSDP/E 49.2

Bicara Therapeutics Inc.

Stoke Therapeutics, Inc.

Zenas BioPharma, Inc.

Generate Biomedicines, Inc.

Taysha Gene Therapies, Inc.

Fortrea Holdings Inc.

MapLight Therapeutics, Inc.

Intellia Therapeutics, Inc.

$1.64BUSDP/E 3.5

$1.54BUSDP/E 30.0

AnaptysBio, Inc.

Recursion Pharmaceuticals, Inc.

MoonLake Immunotherapeutics

Vir Biotechnology, Inc.

ArriVent BioPharma, Inc.

Maze Therapeutics, Inc.

Pharma Mar, S.A.

$1.42BUSDP/E 16.4

Absci Corporation

Aktis Oncology, Inc.

Inhibrx Biosciences, Inc.

First Tracks Biotherapeutics, Inc.

MannKind Corporation

Jade Biosciences, Inc.

Corvus Pharmaceuticals, Inc.

MeiraGTx Holdings plc

Avalyn Pharma Inc.

Philogen S.p.A.

$1.06BUSDP/E 4.2

ORIC Pharmaceuticals, Inc.

Capricor Therapeutics, Inc.

Alto Neuroscience, Inc.

Seaport Therapeutics, Inc.

Cullinan Therapeutics, Inc.

Lexicon Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc.

Kura Oncology, Inc.

Janux Therapeutics, Inc.

Avalo Therapeutics, Inc.

Vor Biopharma Inc.

Arbutus Biopharma Corporation

$936.33MUSDP/E 5.7

Pharming Group N.V.

$879.74MUSDP/E 57.3

Forte Biosciences, Inc.

Geron Corporation

Oxford Biomedica plc

Solid Biosciences Inc.

Sana Biotechnology, Inc.

DBV Technologies S.A.

LB Pharmaceuticals Inc

Phathom Pharmaceuticals, Inc.

$817.88MUSDP/E 3.3

Odyssey Therapeutics, Inc.

Replimune Group, Inc.

CytomX Therapeutics, Inc.

Basilea Pharmaceutica AG

$731.70MUSDP/E 16.5

Design Therapeutics, Inc.

Rigel Pharmaceuticals, Inc.

$770.98MUSDP/E 2.2

Zevra Therapeutics, Inc.

$754.31MUSDP/E 6.3

Aclaris Therapeutics, Inc.

ARS Pharmaceuticals, Inc.

Monopar Therapeutics Inc.

Immix Biopharma, Inc.

Gyre Therapeutics, Inc.

Aura Biosciences, Inc.

XOMA Royalty Corporation

$710.16MUSDP/E 25.6

Candel Therapeutics, Inc.

SpyGlass Pharma, Inc.

Shattuck Labs, Inc.

Faeth Therapeutics, Inc.

Omeros Corporation

$667.30MUSDP/E 8.1

BridgeBio Oncology Therapeutics, Inc.

MiMedx Group, Inc.

$659.83MUSDP/E 22.1

$650.37MUSDP/E 3.8

Allogene Therapeutics, Inc.

Nuvectis Pharma, Inc.

Prime Medicine, Inc.

Tectonic Therapeutic, Inc.

Relmada Therapeutics, Inc.

4D Molecular Therapeutics, Inc.

Altimmune, Inc.

Ginkgo Bioworks Holdings, Inc.

Eikon Therapeutics, Inc.

Contineum Therapeutics, Inc.

Assembly Biosciences, Inc.

$512.08MUSDP/E 323.0

ProKidney Corp.

Sagimet Biosciences Inc.

Ovid Therapeutics Inc.

Kyverna Therapeutics, Inc.

Editas Medicine, Inc.

Artiva Biotherapeutics, Inc.

Cabaletta Bio, Inc.

Benitec Biopharma Inc.

Puma Biotechnology, Inc.

$427.56MUSDP/E 17.5

Crescent Biopharma, Inc.

Century Therapeutics, Inc.

Eupraxia Pharmaceuticals Inc.

Abeona Therapeutics Inc.

$400.11MUSDP/E 7.4

Tenax Therapeutics, Inc.

C4 Therapeutics, Inc.

Upstream Bio, Inc.

Sutro Biopharma, Inc.

DiaMedica Therapeutics Inc.

Enanta Pharmaceuticals, Inc.

Larimar Therapeutics, Inc.

Atea Pharmaceuticals, Inc.

Avacta Group Plc

Rocket Pharmaceuticals, Inc.

Fennec Pharmaceuticals Inc.

X4 Pharmaceuticals, Inc.

Lexeo Therapeutics, Inc.

Indaptus Therapeutics, Inc.

Hansa Biopharma AB (publ)

Vicore Pharma Holding AB (publ)

Prelude Therapeutics Incorporated

Palisade Bio, Inc.

$328.44MUSDP/E 15.8

Vanda Pharmaceuticals Inc.

Zentalis Pharmaceuticals, Inc.

Lyell Immunopharma, Inc.

Fate Therapeutics, Inc.

Inhibikase Therapeutics, Inc.

Immuneering Corporation

Egetis Therapeutics AB (publ)

Foghorn Therapeutics Inc.

Neumora Therapeutics, Inc.

Eledon Pharmaceuticals, Inc.

Lineage Cell Therapeutics, Inc.

Santhera Pharmaceuticals Holding AG

Conexeu Sciences Inc.

SAB Biotherapeutics, Inc.

Greenwich LifeSciences, Inc.

ALX Oncology Holdings Inc.

Galectin Therapeutics Inc.

Oryzon Genomics S.A.

Opus Genetics, Inc.

Niagen Bioscience, Inc.

$270.79MUSDP/E 16.2

Turn Therapeutics Inc.

Entrada Therapeutics, Inc.

MacroGenics, Inc.

$257.91MUSDP/E 5.5

Cartesian Therapeutics, Inc.

Fulcrum Therapeutics, Inc.

Protara Therapeutics, Inc.

Orchestra BioMed Holdings, Inc.

Circio Holding ASA

Anavex Life Sciences Corp.

Precision BioSciences, Inc.

Coherus Oncology, Inc.

Karyopharm Therapeutics Inc.

Keros Therapeutics, Inc.

Nautilus Biotechnology, Inc.

$208.21MUSDP/E 2.4

Atrium Therapeutics, Inc.

Atrys Health, S.A.

CAMP4 THERAPEUTICS CORPORATION

Minerva Neurosciences, Inc.

Onward Medical N.V.

Whitehawk Therapeutics, Inc.

Tonix Pharmaceuticals Holding Corp.

Saniona AB (publ)

$172.17MUSDP/E 7.9

Voyager Therapeutics, Inc.

Tenaya Therapeutics, Inc.

NRx Pharmaceuticals, Inc.

Flerie AB (publ)

Canton Strategic Holdings, Inc.

Korro Bio, Inc.

Outlook Therapeutics, Inc.

Arcturus Therapeutics Holdings Inc.

AN2 Therapeutics, Inc.

Oramed Pharmaceuticals Inc.

$165.75MUSDP/E 1.6

OnKure Therapeutics, Inc.

Caribou Biosciences, Inc.

Corbus Pharmaceuticals Holdings, Inc.

Innate Pharma S.A.

Thor Medical ASA

Equillium, Inc.

Scancell Holdings plc

BioInvent International AB (publ)

Milestone Pharmaceuticals Inc.

LENZ Therapeutics, Inc.

Hyloris Pharmaceuticals SA

Molecular Partners AG

TuHURA Biosciences, Inc.

Pyxis Oncology, Inc.

Aardvark Therapeutics, Inc.

Unicycive Therapeutics, Inc.

Genovis AB (publ.)

$126.38MUSDP/E 54.1

Armata Pharmaceuticals, Inc.

Fractyl Health, Inc.

Heidelberg Pharma AG

Captor Therapeutics Spolka Akcyjna

vTv Therapeutics Inc.

Genelux Corporation

$122.91MUSDP/E 3.2

Spruce Biosciences, Inc.

Cue Biopharma, Inc.

Vivani Medical, Inc.

SynAct Pharma AB

Faron Pharmaceuticals Oy

Fortress Biotech, Inc.

$113.61MUSDP/E 1.1

Anixa Biosciences, Inc.

Kalaris Therapeutics, Inc.

Polaryx Therapeutics, Inc.

Coya Therapeutics, Inc.

Medivir AB (publ)

Aldeyra Therapeutics, Inc.

Black Diamond Therapeutics, Inc.

ImmuCell Corporation

ArcticZymes Technologies ASA

$89.99MUSDP/E 72.5

Verrica Pharmaceuticals Inc.

Nykode Therapeutics AS

$88.03MUSDP/E 11.0

Pelthos Therapeutics Inc.

Rallybio Corporation

Inovio Pharmaceuticals, Inc.

Rani Therapeutics Holdings, Inc.

Infant Bacterial Therapeutics AB (publ)

ABIONYX Pharma SA

Biomea Fusion, Inc.

Ryvu Therapeutics S.A.

Spero Therapeutics, Inc.

$90.91MUSDP/E 5.8

Heron Therapeutics, Inc.

$82.96MUSDP/E 76.3

OSE Immunotherapeutics SA

NeOnc Technologies Holdings, Inc.

Cognition Therapeutics, Inc.

Elicio Therapeutics, Inc.

Gossamer Bio, Inc.

AlzeCure Pharma AB (publ)

Telomir Pharmaceuticals, Inc.

Champions Oncology, Inc.

MAIA Biotechnology, Inc.

Nanoform Finland Oyj

Atara Biotherapeutics, Inc.

Adicet Bio, Inc.

Helix BioPharma Corp.

Acrivon Therapeutics, Inc.

Xspray Pharma AB (publ)

Annovis Bio, Inc.

Rein Therapeutics Inc.

Gain Therapeutics, Inc.

MediciNova, Inc.

PMV Pharmaceuticals, Inc.

Pliant Therapeutics, Inc.

OS Therapies Incorporated

Oncopeptides AB (publ)

Pentixapharm Holding AG N

ImageneBio, Inc.

THX Pharma Société Anonyme

Hemogenyx Pharmaceuticals Plc

Cardiff Oncology, Inc.

Xilio Therapeutics, Inc.

TScan Therapeutics, Inc.

Context Therapeutics Inc.

Boundless Bio, Inc.

INmune Bio Inc.

MiNK Therapeutics, Inc.

BeyondSpring Inc.

Filana Therapeutics, Inc.

Herantis Pharma Oyj

Apollomics, Inc.

Instil Bio, Inc.

aTyr Pharma, Inc.

Seres Therapeutics, Inc.

Impact BioMedical Inc.

Corline Biomedical AB

Cantargia AB (publ)

$43.71MUSDP/E 2.9

Eastwood Bio-Medical Canada Inc.

Metagenomi Therapeutics, Inc.

Dogwood Therapeutics, Inc.

$46.07MUSDP/E 1.2

Dyadic International, Inc.

Synthaverse S.A.

Hyperion DeFi, Inc.

Intervacc AB (publ)

Eloxx Pharmaceuticals, Inc.

Arch Biopartners Inc.

NanoViricides, Inc.

Sprint Bioscience AB (publ)

$36.94MUSDP/E 3.9

PDS Biotechnology Corporation

Actuate Therapeutics, Inc. Common stock

Vivoryon Therapeutics N.V.

Mendus AB (publ)

Sareum Holdings plc

Lantern Pharma Inc.

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.

$41.13MUSDP/E 5.7

genOway Société anonyme

$34.47MUSDP/E 25.7

Aligos Therapeutics, Inc.

Lite Strategy, Inc.

Estrella Immunopharma, Inc.

Lisata Therapeutics, Inc.

Kyntra Bio, Inc.

SkinBioTherapeutics plc

Microbix Biosystems Inc.

Daré Bioscience, Inc.

Tvardi Therapeutics, Inc.

Actinium Pharmaceuticals, Inc.

Plus Therapeutics, Inc.

$26.85MUSDP/E 0.2

GridAI Technologies Corp.

IGC Pharma, Inc.

VYNE Therapeutics Inc.

Isofol Medical AB (publ)

SoftOx Solutions AS

Atossa Therapeutics, Inc.

Medicenna Therapeutics Corp.

Xbrane Biopharma AB (publ)

Resverlogix Corp.

Marker Therapeutics, Inc.

Celularity Inc.

GenSight Biologics S.A.

Jasper Therapeutics, Inc.

ZIVO Bioscience, Inc.

Cellectar Biosciences, Inc.

CEL-SCI Corporation

Devonian Health Group Inc.

Longeveron Inc.

Neuphoria Therapeutics Inc.

Allarity Therapeutics, Inc.

Tevogen Bio Holdings Inc.

Quince Therapeutics, Inc.

Werewolf Therapeutics, Inc.

Diamyd Medical AB (publ)

Xintela AB (publ)

OSR Health, Inc.

$17.05MUSDP/E 16.2

SeaStar Medical Holding Corporation

Simris Group AB (PUBL)

Cyclerion Therapeutics, Inc.

Passage Bio, Inc.

Tempest Therapeutics, Inc.

Vyome Holdings, Inc.

Moleculin Biotech, Inc.

Pasithea Therapeutics Corp.

Nanologica AB (publ)

$13.93MUSDP/E 1.6

Palatin Technologies, Inc.

$15.08MUSDP/E 77.0

Fusion Antibodies plc

Senti Biosciences Holdings, Inc.

HOOKIPA Pharma Inc.

Active Biotech AB (publ)

Alzinova AB (publ)

Citius Pharmaceuticals, Inc.

GT Biopharma, Inc.

Celyad Oncology SA

$12.65MUSDP/E 13.0

Intensity Therapeutics, Inc.

Cocrystal Pharma, Inc.

Lunai Bioworks Inc.

Biovica International AB (publ)

BioCardia, Inc.

NextCell Pharma AB

Alligator Bioscience AB (publ)

IRLAB Therapeutics AB (publ)

Phio Pharmaceuticals Corp.

Kiora Pharmaceuticals, Inc.

CalciMedica, Inc.

Theriva Biologics, Inc.

OncoZenge AB (publ)

Traws Pharma, Inc.

Scandinavian ChemoTech AB

Vistagen Therapeutics, Inc.

Annexin Pharmaceuticals AB (publ)

Brainstorm Cell Therapeutics Inc.

Hemostemix Inc.

Spago Nanomedical AB (publ)

Liminatus Pharma, Inc.

Marinomed Biotech AG

$8.26MUSDP/E 0.4

Plant Advanced Technologies SA

$8.25MUSDP/E 13.1

Aprea Therapeutics, Inc.

Jupiter Neurosciences, Inc.

EXACT Therapeutics AS

Arctic Bioscience AS

Ernexa Therapeutics Inc.

$8.30MUSDP/E 0.0

Aspire Biopharma Holdings, Inc.

Bolt Biotherapeutics, Inc.

TransCode Therapeutics, Inc.

NKGen Biotech, Inc.

AEON Biopharma, Inc.

AIM ImmunoTech Inc.

Addex Therapeutics Ltd

AcouSort AB (publ)

Kairos Pharma, Ltd.

Reviva Pharmaceuticals Holdings, Inc.

Cadrenal Therapeutics, Inc.

Euroespes, S.A.

Pure Biologics S.A.

CNS Pharmaceuticals, Inc.

Ascelia Pharma AB (publ)

Acurx Pharmaceuticals, Inc.

OptiBiotix Health Plc

Jaguar Health, Inc.

HCW Biologics Inc.

Xenetic Biosciences, Inc.

Processa Pharmaceuticals, Inc.

Curanex Pharmaceuticals Inc

Adial Pharmaceuticals, Inc.

Pulmatrix, Inc.

Quantum Genomics Société Anonyme

Aptevo Therapeutics Inc.

$5.61MUSDP/E 0.0

Enveric Biosciences, Inc.

Soligenix, Inc.

Bio Green Med Solution, Inc.

$5.24MUSDP/E 0.2

Dermata Therapeutics, Inc.

Alaunos Therapeutics, Inc.

Cardio Diagnostics Holdings, Inc.

PMGC Holdings Inc.

Mustang Bio, Inc.

Fluicell AB (publ)

$4.34MUSDP/E 0.0

Alzamend Neuro, Inc.

GeoVax Labs, Inc.

Revelation Biosciences, Inc.

FibroBiologics, Inc.

Ensysce Biosciences, Inc.

Strategic Partners A/S

60 Degrees Pharmaceuticals, Inc.

Artelo Biosciences, Inc.

Kane Biotech Inc.

StageZero Life Sciences Ltd.

Guard Therapeutics International AB (publ)

Innovotech Inc.

Lakewood-Amedex Biotherapeutics, Inc.

Decoy Therapeutics Inc.

$3.19MUSDP/E 0.1

Onconetix, Inc.

$2.92MUSDP/E 0.0

$2.73MUSDP/E 0.0

Oragenics, Inc.

Quest PharmaTech Inc.

$2.46MUSDP/E 0.7

Matinas BioPharma Holdings, Inc.

Calidi Biotherapeutics, Inc.

Magle Chemoswed Holding AB (publ)

Clearside Biomedical, Inc.

VivoSim Labs, Inc.

Futura Medical plc

BSF Enterprise Plc

Bio-Path Holdings, Inc.

CDT Equity Inc.

Hepion Pharmaceuticals, Inc.

$1.62MUSDP/E 0.0

Appili Therapeutics Inc.

Lyra Therapeutics, Inc.

Evofem Biosciences, Inc.

ZyVersa Therapeutics, Inc.

Waverley Pharma Inc.

Avenue Therapeutics, Inc.

CERo Therapeutics Holdings, Inc.

$518.8KUSDP/E 0.0

Protagenic Therapeutics, Inc.

Windtree Therapeutics, Inc.

$458.4KUSDP/E 0.0

$449.7KUSDP/E 0.9

Sorrento Therapeutics, Inc.

Lipella Pharmaceuticals Inc.

Carisma Therapeutics, Inc.

$238.5KUSDP/E 0.0

Ocean Biomedical, Inc.

PaxMedica, Inc.

$88.4KUSDP/E 0.0

Vincerx Pharma, Inc.

Panbela Therapeutics, Inc.

Anebulo Pharmaceuticals, Inc.

Scopus BioPharma Inc.

Virpax Pharmaceuticals, Inc.

Vaxxinity, Inc.

Better Therapeutics, Inc.

Aridis Pharmaceuticals, Inc.

Kaleido Biosciences, Inc.

Comera Life Sciences Holdings, Inc.

eFFECTOR Therapeutics, Inc.

Syros Pharmaceuticals, Inc.

Evelo Biosciences, Inc.

NexImmune, Inc.

Idogen AB (publ)

Bitwise MARA Option Income Strategy ETF

Bio Green Med Solution, Inc.

bioAffinity Technologies, Inc.

Biofrontera Inc.

Celularity Inc.

The Oncology Institute, Inc.

Aspire Biopharma Holdings, Inc.

Fortress Biotech, Inc.

HeartSciences Inc.

AB Corporate Bond ETF

Dermata Therapeutics, Inc.

XOMA Royalty Corporation

XOMA Royalty Corporation

Cardio Diagnostics Holdings, Inc.

CDT Equity Inc.

60 Degrees Pharmaceuticals, Inc.

Indicators:|

Headline	Source	Time
Yesterday
Slate Medicines Appoints Mark W. Hahn to Board of Directors By Daniella Parra Slate Medicines, a private biotech company developing new treatments for migraine and other headache disorders, has appointed Mark W. Hahn to its Board of Directors, they said. The company said Hahn brings more than 25 years of life sciences leadership experience, including serving as CFO of Verona Pharma, where he helped guide […] The post Slate Medicines Appoints Mark W. Hahn to Board of Directors appeared first on ExecEdge.	Exec Edge	1d
This week
All You Need to Know About Acumen Pharmaceuticals (ABOS) Rating Upgrade to Buy Acumen Pharmaceuticals (ABOS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).	Zacks	Jul 15
Are Medical Stocks Lagging Acumen Pharmaceuticals (ABOS) This Year? Here is how Acumen Pharmaceuticals, Inc. (ABOS) and Amarin (AMRN) have performed compared to their sector so far this year.	Zacks	Jul 15
Older
Acumen Nominates 2 Therapies to Treat Alzheimer’s Disease	Exec Edge	Jun 16
Acumen Pharmaceuticals Inc (ABOS) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ...	GuruFocus.com	May 12
Acumen Pharmaceuticals Q1 Earnings Call Highlights	MarketBeat	May 12
Acumen Pharmaceuticals (ABOS) Loses 33.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner	Zacks	Mar 31
Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?	Zacks	Mar 30
Acumen Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary	Moby	Mar 27
Acumen Pharmaceuticals Inc (ABOS) Q4 2025 Earnings Call Highlights: Strategic Advances Amid ...	GuruFocus.com	Mar 26
Acumen Pharmaceuticals Q4 Earnings Call Highlights	MarketBeat	Mar 26
Acumen Pharmaceuticals Spotlights Sabirnetug Phase II Progress, JCR Brain-Delivery Partnership at Conference	MarketBeat	Mar 19
Acumen Pharma Presents Brain Delivery Studies at Alzheimer’s and Parkinson’s Diseases Conference 2026	Exec Edge	Mar 17